The Spanish Society of Endocrinology and Nutrition (SEEN) has issued a statement on the use of this antigen.
The Spanish Society of Endocrinology and Nutrition (SEEN) has issued a statement on the use of the AstraZeneca Covid-19 vaccine. In this statement, endorsed by the Federation of Spanish Scientific Medical Associations (Facme), the organization informs that this antigen “it does not present any safety or efficacy problem among patients with diabetes mellitus and / or other endocrinological or metabolic diseases ”.
In the latest update of the Vaccination Strategy of the Ministry of Health, it is indicated in relation to the AstraZeneca vaccine that its use is recommended in people between 18 and 55 years of age, except those with severe immunosuppression, uncontrolled cardiovascular disease and liver and kidney disease. severe metabolic / endocrine or neurological.
This exclusion is not due to concerns regarding safety. The clinical trials evaluated for the authorization of the AstraZeneca vaccine included 39.3% of people with other associated diseases, such as cardiovascular diseases, respiratory diseases or diabetes, without observing differences in their efficacy or safety.
Efficacy in participants with one or more comorbidities It was 58.3%, similar to that observed in the general population.
The vaccination strategy of the Ministry of Health considers that people with type 2 diabetes mellitus or obesity have a higher risk of serious disease associated with Covid-19 with solid scientific evidence and people with type 1 diabetes mellitus are considered people with a higher risk of serious illness associated with Covid-19 but with medium or low scientific evidence.
For this reason, from the SEEN they report that people with diabetes “must be vaccinated with authorized vaccines against Covid-19, and thus reduce their individual risk of serious disease associated with this virus ”.
Likewise, in unstable or decompensated clinical situations (for example, hyperglycemia or hypoglycemia that have required recent urgent medical attention) “vaccination can be postponed until clinical recovery ”.